Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: A retrospective study
This study analyzed 245 adenomyosis patients, finding that lesion characteristics, uterine and lesion location, and patient abdominal wall thickness predict high intensity focused ultrasound ablative efficiency.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (20)
- Adenomyosis: a neglected diagnosis. via openalex
- Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation via openalex
- Effective ablation therapy of adenomyosis with ultrasound-guided high-intensity focused ultrasound via openalex
- Effects of oxytocin on high intensity focused ultrasound (HIFU) ablation of adenomysis: a prospective study via openalex
- Feasibility of laparoscopic high-intensity focused ultrasound treatment for patients with uterine localized adenomyosis via openalex
- Imaging features of adenomyosis via openalex
- Pathologic findings from the Maryland Women's Health Study: practice patterns in the diagnosis of adenomyosis via openalex
- Safety and efficacy of high intensity focused ultrasound ablation therapy for adenomyosis via openalex
- Surgical and medical treatment of adenomyosis via openalex
- The elusive adenomyosis of the uterus--revisited via openalex
- Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center via openalex
- Ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation for the treatment of patients with adenomyosis and prior abdominal surgical scars: A retrospective study via openalex
- W2766403853 via openalex
- W1967197865 via openalex
- W1981755049 via openalex
- W2026769272 via openalex
- W2087831276 via openalex
- W2103284425 via openalex
- W2104825245 via openalex
- W2410786902 via openalex
Cited by (30)
- Prediction of clinical outcome for high-intensity focused ultrasound ablation of adenomyosis based on non-enhanced MRI radiomics 2025
- Non-surgical Treatment of Adenomyosis 2024
- High-intensity focused ultrasound for endometrial ablation in adenomyosis: a clinical study 2024
- High-intensity focused ultrasound in adenomyosis treatment: Insights on safety, efficacy, and reproductive prospects 2024
- Non-contrast enhanced MRI for efficiency evaluation of high-intensity focused ultrasound in adenomyosis ablation 2024
- Efficacy and safety of percutaneous microwave ablation for adenomyosis in the posterior uterine wall 2023
- Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation for adenomyosis has short- and long-term benefits: a single-center study 2023
- Current Trends of Alternatives to Hysterectomy in Adenomyosis: A Review Article 2023
- Comparison of the treatment efficacies of HIFU, HIFU combined with GnRH-a, and HIFU combined with GnRH-a and LNG-IUS for adenomyosis: A systematic review and meta-analysis 2023
- High-intensity focused ultrasound for endometrial ablation in adenomyosis: A clinical study 2023
- Classifications of Adenomyosis and Correlation of Phenotypes in Imaging and Histopathology to Clinical Outcomes: a Review 2022
- Doppler Imaging Assessment of Changes of Blood Flow in Adenomyosis After Higher-Dose Oxytocin: A Randomized Controlled Trial 2022
- Magnetic resonance imaging T2WI hyperintense foci number and the prognosis of adenomyosis after high-intensity focused ultrasound treatment 2021
- Objective measures of adenomyosis on MRI and their diagnostic accuracy-a systematic review & meta-analysis 2021
- Adenomyosis and HIFU Ablation 2021
- Microbubble contrast agent SonoVue combined with oxytocin improves the efficiency of high-intensity focused ultrasound ablation for adenomyosis 2021
- Image-guided thermal ablation in the management of symptomatic adenomyosis: a systematic review and meta-analysis 2021
- Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation for adenomyosis: preliminary results 2019
- Classification and Reporting Systems for Adenomyosis 2019
- Effect of pre-treatment with gonadotropin-releasing hormone analogue GnRH-α on high-intensity focussed ultrasound ablation for diffuse adenomyosis: a preliminary study 2018
- Influences of screening magnetic resonance imaging parameters on high-intensity focused ultrasound outcome for adenomyosis 2018
- Minimally invasive treatment of adenomyosis 2018
- Magnetic resonance imaging features influencing high-intensity focused ultrasound ablation of adenomyosis with a nonperfused volume ratio of ≥90% as a measure of clinical treatment success: retrospective multivariate analysis 2018
- Clinical Usefulness of the Microbubble Contrast Agent SonoVue in Enhancing the Effects of High-Intensity Focused Ultrasound for the Treatment of Adenomyosis 2018
- Comparison of effectiveness of epidural analgesia and monitored anesthesia care for high-intensity focused ultrasound treatment of adenomyosis 2018
- Percutaneous microwave ablation with artificial ascites for symptomatic uterine adenomyosis: initial experience 2017
- High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility 2017
- Treatment options and reproductive outcome for adenomyosis-associated infertility 2017
- The role of T1 perfusion-based classification in predicting the outcome of magnetic resonance-guided high-intensity focused ultrasound treatment of adenomyosis 2017
- Ultrasound-guided transcervical radiofrequency ablation for symptomatic uterine adenomyosis 2016
Source provenance
- europepmc
- last seen: 2026-10-17T06:09:56.316927+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:18:11.460223+00:00